Status:
COMPLETED
Recurrence of Hepatocellular Carcinoma
Lead Sponsor:
Ain Shams University
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18-70 years
Brief Summary
analysis of the risk factors of intra-hepatic distant recurrence (IDR) of hepatocellular carcinoma within 1 year after radiofrequency ablation.
Eligibility Criteria
Inclusion
- Proved diagnosis of HCC according to AASLD practice guidelines (Bruix and Sherman, 2005).
- Patients underwent RFA for HCC with BCLC (The Barcelona-Clinic- Liver-Cancer staging system) stage A (Bruix and Sherman, 2005) with no eligibility or ability to do transplantation or resection.
- Patients should be followed-up for more than 12 months to exclude early recurrence i.e. recurrence within 1 year.
- Patients with INR \< 1.5 or prothrombin concentration \> 50%.
- Platelet count \> 50000 cell/mm3.
Exclusion
- Presence of extra-hepatic metastasis or gross vascular invasion.
- Child class C patients.
- Follow up period of less than 12 months.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT01520779
Start Date
January 1 2012
End Date
December 1 2012
Last Update
October 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tropical medicine department
Cairo, Egypt